# DiaMedica Therapeutics Inc.: Form 8-K, filed Jun 4, 2019

- Company: [DiaMedica Therapeutics Inc.](/companies/dmac.md) (CIK 1401040)
- Form: 8-K
- Filed: 2019-06-04
- Accepted by EDGAR: Jun 4, 2019, 07:30 ET
- Period: 2019-05-31
- Accession: 0001437749-19-011313
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1401040/000143774919011313/dmtp20190603_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1401040/000143774919011313/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 3.03: Change to security holders’ rights
- Item 5.03: Amendment to articles or bylaws
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1401040/000143774919011313/dmtp20190603_8k.htm

Filed Jun 4, 2019.
Source: SEC EDGAR, the filing index for accession 0001437749-19-011313. Last ingested by Listed: Oct 24, 2026, 15:09 ET. No prices; not investment advice.